Congress quietly subsidizes corporate reshoring with $40B+ tax credit

What it does

This bill creates a 40% tax credit for companies that build or expand manufacturing facilities in the U.S. for critical products—pharmaceuticals, semiconductors, aerospace equipment, and medical devices—but only if those facilities are located in Puerto Rico or other U.S. possessions, or in economically distressed zones. It also increases the tax credit for foreign taxes paid to U.S. possessions from 80% to 100%, effectively subsidizing corporate tax payments to Puerto Rico.

Why we flagged it

The bill's core mechanism is a 40% investment tax credit for manufacturing facilities, structured as a direct reduction in corporate tax liability. While framed as 'supply chain security,' the primary effect is tax relief for corporations meeting specified criteria, with secondary provisions benefiting Puerto Rico tax arrangements.

• Section 3 increases the deemed credit for taxes paid to U.S. possessions from 80% to 100%, unrelated to reshoring or supply-chain manufacturing and appears to benefit existing Puerto Rico operations.

What the text implies

• The 40% credit applies to the full basis of property placed in service, potentially allowing companies to claim credits on equipment, land, and infrastructure with no wage, employment, or local-benefit requirements—meaning the subsidy may not translate to jobs for distressed-zone residents.
• The 'economically distressed zone' definition requires both qualified opportunity zone status AND 30% poverty rate, a narrow geographic filter that may exclude many struggling communities and concentrate benefits in specific regions.

The full analysis lists 5 implications of this text.

Who stands to gain

pharmaceutical manufacturers; semiconductor companies; aerospace manufacturers